JIM

Jupiter Investment Management Portfolio holdings

AUM $6.26B
1-Year Est. Return 13.19%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+13.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.26B
AUM Growth
+$1.14B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
512
New
Increased
Reduced
Closed

Top Buys

1 +$91.4M
2 +$59.4M
3 +$56.2M
4
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$48.8M
5
META icon
Meta Platforms (Facebook)
META
+$47.4M

Top Sells

1 +$116M
2 +$88.3M
3 +$71.1M
4
COST icon
Costco
COST
+$67.4M
5
VRSN icon
VeriSign
VRSN
+$58.9M

Sector Composition

1 Technology 26.2%
2 Healthcare 15.76%
3 Financials 14.22%
4 Consumer Discretionary 11.22%
5 Communication Services 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NWL icon
376
Newell Brands
NWL
$1.39B
$171K ﹤0.01%
+10,781
DVAX
377
DELISTED
Dynavax Technologies
DVAX
$168K ﹤0.01%
+19,018
BBWI icon
378
Bath & Body Works
BBWI
$3.77B
$166K ﹤0.01%
+13,762
TWO
379
Two Harbors Investment
TWO
$1.3B
$155K ﹤0.01%
7,709
-56,782
EGIO
380
DELISTED
Edgio, Inc. Common Stock
EGIO
$149K ﹤0.01%
+509
ITUB icon
381
Itaú Unibanco
ITUB
$86.6B
$122K ﹤0.01%
35,870
-184,023
BBD icon
382
Banco Bradesco
BBD
$37.1B
$117K ﹤0.01%
37,159
-229,174
ABEV icon
383
Ambev
ABEV
$50.6B
$66K ﹤0.01%
25,000
-129,400
CX icon
384
Cemex
CX
$18.8B
$33K ﹤0.01%
11,600
-41,200
AA icon
385
Alcoa
AA
$22.1B
-72,640
ALGN icon
386
Align Technology
ALGN
$11.9B
-155,175
AMP icon
387
Ameriprise Financial
AMP
$40B
-78,541
AMT icon
388
American Tower
AMT
$86.4B
-1,447
APA icon
389
APA Corp
APA
$13.4B
-48,281
AR icon
390
Antero Resources
AR
$11.2B
-162,518
AZO icon
391
AutoZone
AZO
$49.6B
-16,117
BAC icon
392
Bank of America
BAC
$372B
-517,439
BG icon
393
Bunge Global
BG
$25.1B
-6,530
BGC icon
394
BGC Group
BGC
$4.95B
-14,761
BKR icon
395
Baker Hughes
BKR
$64B
-107,364
BRFS
396
DELISTED
BRF SA
BRFS
-16,300
BSBR icon
397
Santander
BSBR
$41B
-14,720
C icon
398
Citigroup
C
$224B
-7,192
CDW icon
399
CDW
CDW
$17.8B
-178,286
CHRS icon
400
Coherus Oncology
CHRS
$234M
-94,865